{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:02:42Z","timestamp":1783191762676,"version":"3.54.6"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,8]]},"DOI":"10.7759\/cureus.87514","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T08:59:02Z","timestamp":1751965142000},"source":"Crossref","is-referenced-by-count":1,"title":["A Delayed Adverse Reaction: Hydralazine-Induced Lupus After Years of Use"],"prefix":"10.7759","author":[{"given":"Saurav","family":"Paudel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushma","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarup Sharma","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Drug-induced lupus erythematosus","author":"Solhjoo M","year":"2025","unstructured":"Solhjoo M, Goyal A, Chauhan K. Drug-induced lupus erythematosus. In: StatPearls [Internet] (ed): StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.05.039","article-title":"New-onset systemic lupus erythematous in a patient receiving risankizumab for psoriasis","volume":"25","author":"Barber C","year":"2022","unstructured":"Barber C, Song EJ. New-onset systemic lupus erythematous in a patient receiving risankizumab for psoriasis. JAAD Case Rep. 2022, 25:104-6. 10.1016\/j.jdcr.2022.05.039","journal-title":"JAAD Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72069","article-title":"Drug-induced systemic lupus erythematosus: a rare presentation of hydralazine-induced lupus","volume":"16","author":"Jerome R","year":"2024","unstructured":"Jerome R, Randhawa JS, Badran S, Li S, Mohammadi N. Drug-induced systemic lupus erythematosus: a rare presentation of hydralazine-induced lupus. Cureus. 2024, 16:e72069. 10.7759\/cureus.72069","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4996","article-title":"Clinical characteristics of hydralazine-induced lupus","volume":"11","author":"Timlin H","year":"2019","unstructured":"Timlin H, Wu M, Crespo-Bosque M, et al.. Clinical characteristics of hydralazine-induced lupus. Cureus. 2019, 11:e4996. 10.7759\/cureus.4996","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.04.018","article-title":"Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial","volume":"114","author":"Ferdinand KC","year":"2014","unstructured":"Ferdinand KC, Elkayam U, Mancini D, et al.. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. Am J Cardiol. 2014, 114:151-9. 10.1016\/j.amjcard.2014.04.018","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00573.x","article-title":"Hydralazine-induced lupus erythematosis","volume":"14","author":"Handler J","year":"2012","unstructured":"Handler J. Hydralazine-induced lupus erythematosis. J Clin Hypertens (Greenwich). 2012, 14:133-6. 10.1111\/j.1751-7176.2011.00573.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5245904","article-title":"Hydralazine induced lupus syndrome presenting with recurrent pericardial effusion and a negative antinuclear antibody","volume":"2017","author":"Iyer P","year":"2017","unstructured":"Iyer P, Dirweesh A, Zijoo R. Hydralazine induced lupus syndrome presenting with recurrent pericardial effusion and a negative antinuclear antibody. Case Rep Rheumatol. 2017, 2017:5245904. 10.1155\/2017\/5245904","journal-title":"Case Rep Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83202","article-title":"Double trouble: a case report of hydralazine-induced vasculitis and lupus","volume":"17","author":"Ibrahim M","year":"2025","unstructured":"Ibrahim M, Aung T, Penumarty S. Double trouble: a case report of hydralazine-induced vasculitis and lupus. Cureus. 2025, 17:e83202. 10.7759\/cureus.83202","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18648","article-title":"Lyme borreliosis as a trigger for autoimmune disease","volume":"13","author":"Yehudina Y","year":"2021","unstructured":"Yehudina Y, Trypilka S. Lyme borreliosis as a trigger for autoimmune disease. Cureus. 2021, 13:e18648. 10.7759\/cureus.18648","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/096120339500400209","article-title":"False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis","volume":"4","author":"Weiss NL","year":"1995","unstructured":"Weiss NL, Sadock VA, Sigal LH, Phillips M, Merryman PF, Abramson SB. False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis. Lupus. 1995, 4:131-7. 10.1177\/096120339500400209","journal-title":"Lupus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1921","article-title":"Hydralazine-induced systemic lupus erythematosus: a clinical investigation","volume":"211","author":"Shams M","year":"2025","unstructured":"Shams M, Tse J, Nassiri M, Mabunga K, Hansra R, Raj V, Jen K-Y. Hydralazine-induced systemic lupus erythematosus: a clinical investigation. Am J Respir Crit Care Med. 2025, 211:1921. 10.1164\/ajrccm.2025.211.Abstracts.A1921","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.31486\/toj.18.0128","article-title":"Hydralazine-induced isolated lupus nephritis","volume":"20","author":"Khan N","year":"2020","unstructured":"Khan N, Reichel R, Khurshid A, Tso K, Broussard J, Dass A. Hydralazine-induced isolated lupus nephritis. Ochsner J. 2020, 20:187-92. 10.31486\/toj.18.0128","journal-title":"Ochsner J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386382-a-delayed-adverse-reaction-hydralazine-induced-lupus-after-years-of-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T08:59:03Z","timestamp":1751965143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386382-a-delayed-adverse-reaction-hydralazine-induced-lupus-after-years-of-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.87514","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,8]]}}}